What is the fair value of Danaher Corporation (NYSE-DHR) stock?

The current fair value estimate for Danaher Corporation (NYSE-DHR) is $207.53. This implies an estimated downside of 10.0% versus the current market price.

Is Danaher Corporation (NYSE-DHR) undervalued or overvalued?

Based on the current fair value estimate, the stock appears overvalued, with estimated downside of 10.0% versus the current market price.

What is the analyst price target for NYSE-DHR stock?

The available analyst price target for Danaher Corporation (NYSE-DHR) is $259.19. The analyst target implies estimated upside of 12.4%.

How is the financial health of Danaher Corporation?

The current financial health read for Danaher Corporation (NYSE-DHR) is Good. This should be reviewed alongside valuation, profitability, debt and cash-flow quality metrics.

When is Danaher Corporation's next earnings date?

The next earnings date currently listed for Danaher Corporation (NYSE-DHR) is February 3, 2027.

Does Danaher Corporation (NYSE-DHR) pay dividends?

Based on the current data, dividend yield is 0.7%.

What is the P/E ratio for Danaher Corporation (NYSE-DHR)?

The current P/E ratio listed for Danaher Corporation (NYSE-DHR) is 37.8x. Use it together with growth, margins and sector comparisons rather than as a standalone valuation signal.

What is the market capitalization of Danaher Corporation?

The current market capitalization listed for Danaher Corporation is 162.2 B.

What is the enterprise value of Danaher Corporation?

The current enterprise value listed for Danaher Corporation is 184.3 B. Enterprise value can provide a broader valuation view than market capitalization alone because it also considers net debt.

What is the ticker symbol for Danaher Corporation?

The ticker symbol for Danaher Corporation is NYSE-DHR, and the stock is listed on NYSE.

Where is Danaher Corporation (NYSE-DHR) listed?

Danaher Corporation (NYSE-DHR) is listed on NYSE.

What is the debt-to-total-capital ratio for Danaher Corporation?

The current debt-to-total-capital ratio listed for Danaher Corporation is 14.6%, which helps investors evaluate the company’s financing structure and leverage profile.

What is the free float for Danaher Corporation?

The free float listed for Danaher Corporation is 89.0%. Free float helps investors understand how much of the share base is available for public trading.

Danaher Corporation (DHR) Fair Value & Stock Analysis

Danaher Corporation (DHR)

Danaher Corporation is a diversified healthcare company listed on the NYSE under the ticker DHR. As a common stock issuer, it develops and commercializes products and services used in professional, medical, research, and industrial settings across the United States, China, and other international markets. The company reports operations through three segments: Biotechnology, Life Sciences, and Diagnostics. Its portfolio includes tools and consumables for therapeutic development and manufacturing, instruments and reagents for scientific research, and clinical systems used to support disease diagnosis and treatment decisions. Danaher was incorporated in 1969, adopted its current name in 1984, and is headquartered in Washington, D.C.

Stock Summary Fair Value Profitability & Growth Quality & Risk Events & Dividends Market Outlook FAQ

Jump directly to the stock analysis sections supported by the latest available data.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.

Ticker	Fair Value	Fair Value Upside/Downside	Fair Value Rating	Analyst Price Target	Analyst Target Upside/Downside	Analyst Target Rating	Overall Financial Health	Dividend Yield	Next Earnings Date	P/E Ratio	Price-to-Book Ratio	Price-to-Sales Ratio	Market Cap	Enterprise Value	Total Debt / Total Capital	Free Float / Shares Outstanding	Altman Z-Score	Payout Ratio	Free Cash Flow / Net Income
NYSE-DHR	$207.53	-10.0% Downside	Fair	$259.19	12.4% Upside	Fair	Good	0.7%	February 3, 2027	37.8x	3.0x	6.3x	162.2 B	184.3 B	14.6%	89.0%	7.3	23.5%	133.5%